A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men

Journal of Andrology

Volumn 19, Issue 6, 1998, Pages 761-768

  Zhang, Gui Yuan ^a   Gu, Yi Qun ^b   Wang, Xing Hai ^c   Cui, Yu Gui ^d   Bremner, William J ^b,e,f  

^a NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Jiangsu Family Planning Institute   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

^e Medical Service 111   (United States)

^f Department of Medicine ^*  (United States)

Author keywords

Estrogen; FSH; LH; SHBG; Testosterone

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; HUMAN; HYPOGONADISM; INTRAMUSCULAR DRUG ADMINISTRATION; KLINEFELTER SYNDROME; MALE; MEAN RESIDENCE TIME; PHARMACOKINETICS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AREA UNDER CURVE; ESTRADIOL; GONADOTROPINS; HUMANS; HYPOGONADISM; INJECTIONS, INTRAMUSCULAR; MALE; PROLACTIN; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 0032422573     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Anderson DC. Sex-Hormone-binding globulin. Clin Endocrinol (Oxf) 1974;3:69-96.
2. Bagatell CJ, Bremner WJ. Androgens in men: uses and abuses. N Engl J Med 1996;334:707-714.
3. Bagatell CJ, Matsumoto AM, Christensen RB, River JE, Bremner WJ. Comparison of a gonadotropin-releasing hormone antagonist plus tes-tosterone (T) versus T alone as potential male contraceptive regimens. J Clin Endocrinol Metab 1993;77:427-432.
4. Behre HM, Oberpenning F, Nieschlag E. Comparative pharmacokinetics of testosterone preparation: application of computer analysis and simulation. In: Nieschlag E, Behre HM, eds. Testosterone - action, deficiency, substitution. Berlin: Springer-Verlag; 1990:115-135.
5. Behre HM, Klein B, Steinmeyer E, McGregor GP, Voigt K, Nieschlag E. Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotropin-releasing hormone antagonist cetrorelix (SB-75) in normal men. J Clin Endocrinol Metab 1992a;75:393-398.